Reimagining the future of healthcare

LENA / Epilepsy Community Advocate

Home hero advocate lena

Press Releases

Nov 21, 2024
uniQure Announces Dosing of First Patient in GenTLE Phase I/IIa Clinical Trial of AMT-260 for the Treatment of Refractory Mesial Temporal Lobe Epilepsy
Nov 5, 2024
uniQure Announces Third Quarter 2024 Financial Results and Highlights Recent Company Progress
Oct 15, 2024
uniQure Announces Dosing of First Patient in Phase I/II Clinical Trial of AMT-162 for the Treatment of SOD1-ALS

See All